Organon & Co (OGN)
21.80
+0.28
(+1.30%)
USD |
NYSE |
May 17, 16:00
21.90
+0.10
(+0.46%)
After-Hours: 20:00
Organon Enterprise Value: 13.75B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 13.75B |
May 16, 2024 | 13.67B |
May 15, 2024 | 13.71B |
May 14, 2024 | 13.63B |
May 13, 2024 | 13.52B |
May 10, 2024 | 13.39B |
May 09, 2024 | 13.41B |
May 08, 2024 | 13.38B |
May 07, 2024 | 13.39B |
May 06, 2024 | 13.46B |
May 03, 2024 | 13.18B |
May 02, 2024 | 13.15B |
May 01, 2024 | 12.98B |
April 30, 2024 | 12.92B |
April 29, 2024 | 13.00B |
April 26, 2024 | 12.91B |
April 25, 2024 | 12.88B |
April 24, 2024 | 12.95B |
April 23, 2024 | 12.90B |
April 22, 2024 | 12.77B |
April 19, 2024 | 12.72B |
April 18, 2024 | 12.73B |
April 17, 2024 | 12.73B |
April 16, 2024 | 12.71B |
April 15, 2024 | 12.69B |
Date | Value |
---|---|
April 12, 2024 | 12.63B |
April 11, 2024 | 12.84B |
April 10, 2024 | 12.81B |
April 09, 2024 | 12.87B |
April 08, 2024 | 12.81B |
April 05, 2024 | 12.71B |
April 04, 2024 | 12.71B |
April 03, 2024 | 12.72B |
April 02, 2024 | 12.78B |
April 01, 2024 | 12.87B |
March 31, 2024 | 12.95B |
March 28, 2024 | 12.87B |
March 27, 2024 | 12.78B |
March 26, 2024 | 12.70B |
March 25, 2024 | 12.62B |
March 22, 2024 | 12.61B |
March 21, 2024 | 12.75B |
March 20, 2024 | 12.71B |
March 19, 2024 | 12.65B |
March 18, 2024 | 12.62B |
March 15, 2024 | 12.74B |
March 14, 2024 | 12.76B |
March 13, 2024 | 12.81B |
March 12, 2024 | 12.74B |
March 11, 2024 | 12.76B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.592B
Minimum
Jun 09 2021
18.38B
Maximum
Mar 02 2022
14.70B
Average
14.64B
Median
Enterprise Value Benchmarks
Amgen Inc | 221.93B |
Pfizer Inc | 219.35B |
Pacira BioSciences Inc | 1.629B |
Amphastar Pharmaceuticals Inc | 2.431B |
Moderna Inc | 42.41B |
Enterprise Value Related Metrics
Net Income (Quarterly) | 201.00M |
Revenue (Quarterly) | 1.622B |
Total Expenses (Quarterly) | 1.208B |
EPS Diluted (Quarterly) | 0.78 |
Gross Profit Margin (Quarterly) | 59.00% |
Profit Margin (Quarterly) | 12.39% |
Earnings Yield | 18.76% |
Operating Earnings Yield | 24.06% |
Normalized Earnings Yield | 20.70 |